Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Liquidia Corporation(LQDA) | 8,118,892 | 8,118,892 | 0 | $280.02M | $306.41M | 21.67% | +$26.39M |
| ABIVAX Société AnonymeADS(ABVX) | 1,451,924 | 1,461,924 | +10,000 | $195.80M | $162.79M | 11.51% | -$33.01M |
| Revolution Medicines, Inc.(RVMD) | 1,283,900 | 1,652,808 | +368,908 | $102.26M | $160.74M | 11.37% | +$58.47M |
| Vaxcyte, Inc.(PCVX) | 1,704,815 | 2,060,719 | +355,904 | $78.66M | $119.75M | 8.47% | +$41.09M |
| Xenon Pharmaceuticals Inc.(XENE) | 549,665 | 1,393,027 | +843,362 | $24.64M | $81.00M | 5.73% | +$56.37M |
| Mineralys Therapeutics, Inc.(MLYS) | 2,772,654 | 2,772,654 | 0 | $100.62M | $75.11M | 5.31% | -$25.51M |
| Exelixis, Inc.(EXEL) | 1,553,262 | 1,553,262 | 0 | $68.08M | $66.62M | 4.71% | -$1.46M |
| Tango Therapeutics, Inc.(TNGX) | 3,729,895 | 2,408,798 | -1,321,097 | $33.05M | $50.39M | 3.56% | +$17.35M |
| Tyra Biosciences, Inc.(TYRA) | 944,257 | 1,276,968 | +332,711 | $24.82M | $48.91M | 3.46% | +$24.08M |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 878,127 | +878,127 | $0 | $44.29M | 3.13% | +$44.29M |
| Adma Biologics Inc | 3,012,508 | 4,756,511 | +1,744,003 | $54.95M | $42.86M | 3.03% | -$12.09M |
| LB Pharmaceuticals Inc(LBRX) | 0 | 1,438,070 | +1,438,070 | $0 | $34.63M | 2.45% | +$34.63M |
| Vor Biopharma Inc.(VOR) | 925,067 | 1,925,066 | +999,999 | $9.96M | $34.34M | 2.43% | +$24.38M |
| SAB Biotherapeutics, Inc.(SABS) | 0 | 7,967,207 | +7,967,207 | $0 | $30.51M | 2.16% | +$30.51M |
| Opus Genetics, Inc.(IRD) | 0 | 6,075,028 | +6,075,028 | $0 | $27.64M | 1.96% | +$27.64M |
| Inventiva S.A.ADS(IVA) | 2,000,000 | 4,974,906 | +2,974,906 | $9.30M | $27.61M | 1.95% | +$18.31M |
| MBX Biosciences, Inc.(MBX) | 0 | 848,590 | +848,590 | $0 | $25.33M | 1.79% | +$25.33M |
| Avalo Therapeutics, Inc.(AVTX) | 881,533 | 1,635,023 | +753,490 | $16.01M | $24.41M | 1.73% | +$8.40M |
| Anika Therapeutics Inc | 1,435,130 | 1,435,130 | 0 | $13.79M | $20.81M | 1.47% | +$7.02M |
| Maze Therapeutics, Inc.(MAZE) | 550,191 | 614,962 | +64,771 | $22.79M | $18.36M | 1.30% | -$4.44M |
| Verrica Pharmaceuticals Inc.(VRCA) | 923,910 | 923,910 | 0 | $7.68M | $4.89M | 0.35% | -$2.79M |
| Faeth Therapeutics, Inc.(FTH) | 0 | 126,002 | +126,002 | $0 | $3.97M | 0.28% | +$3.97M |
| Aura Biosciences, Inc.(AURA) | 0 | 229,864 | +229,864 | $0 | $1.54M | 0.11% | +$1.54M |
| Xilio Therapeutics, Inc.(XLO) | 0 | 112,128 | +112,128 | $0 | $943.0K | 0.07% | +$943.0K |
| Eledon Pharmaceuticals, Inc.(ELDN) | 555,978 | 0 | -555,978 | $839.5K | $0 | — | -$839.5K |
| Inhibrx Biosciences, Inc.(INBX) | 323,565 | 0 | -323,565 | $25.56M | $0 | — | -$25.56M |
| Rapt Therapeutics Inc | 644,400 | 0 | -644,400 | $21.83M | $0 | — | -$21.83M |
| Spruce Biosciences Inc | 20,514 | 0 | -20,514 | $1.79M | $0 | — | -$1.79M |